Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer.

Willett CG, Daly WJ, Warshaw AL. CA 19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer. Am J Surg. 1996 Oct; 172(4):350-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.